Notify me when GREG ZANTE files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VKTX | Viking Therapeutics, Inc. | Chief Financial Officer | $6,093,355 | -$2,231,878 | -27% | 02 Jan 2026 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|